# ONI

> ONI (Oxford Nanoimaging) is an Oxford University spinout that shrank the super-resolution microscope from a room-sized, six-figure instrument into a desktop box the size of a sheet of A4 paper. Its flagship Nanoimager resolves single molecules down to 20 nm and pairs with the cloud-based CODI platform for analysis and collaboration, opening single-molecule science to labs studying everything from extracellular vesicles to lipid nanoparticles and cancer.

- **Founded:** 2016
- **Headquarters:** Oxford, United Kingdom
- **Founders:** Bo Jing (Co-founder & founding CEO (2016-2023)), Achillefs Kapanidis (Co-founder & Professor of Biological Physics, University of Oxford), Jeremy Warren (Co-founder & initial CEO)
- **Team size:** Approximately 160 employees
- **Products:** Nanoimager, CODI, Aplo Scope, Aplo Flow, Reagent & consumable kits
- **Notable:** Invented the first desktop super-resolution single-molecule imaging platform, the Nanoimager, Raised over $110M across multiple rounds, including a $75M Series B in 2022 led by ARCH Venture Partners and Casdin Capital, Won the Institute of Physics Business Start-up Award 2018

## Products & services

- **Nanoimager** — Desktop super-resolution single-molecule fluorescence microscope with roughly an A4-page footprint (21 x 15 x 21 cm). Resolves structures down to 20 nm with ~2 nm localization precision. Supports SMLM/dSTORM super-resolution, single-particle tracking in live cells, confocal modes, and smFRET.
- **CODI** — Cloud-based analysis and collaboration platform for microscopy data. Runs analysis workflows in the browser and lets researchers share datasets and pipelines from anywhere.
- **Aplo Scope** — Single-molecule super-resolution microscopy instrument introduced in January 2025, extending ONI's imaging portfolio.
- **Aplo Flow** — Flow-based single-particle analysis instrument for higher-throughput nanoparticle characterization.
- **Reagent & consumable kits** — Sample-preparation and imaging kits, including dedicated extracellular vesicle (EV) imaging kits, plus free open-source CODI tools (EVP2 Axis, LNP Axis) for nanoparticle analysis.

## Achievements

- Invented the first desktop super-resolution single-molecule imaging platform, the Nanoimager
- Raised over $110M across multiple rounds, including a $75M Series B in 2022 led by ARCH Venture Partners and Casdin Capital
- Won the Institute of Physics Business Start-up Award 2018
- Featured on Fast Track's 'Disruptors to Watch' list (2018)
- Launched Aplo Scope in January 2025, expanding the single-molecule imaging portfolio
- Released free open-source CODI tools (EVP2 Axis, LNP Axis) to broaden access to nanoparticle analysis

## Latest updates

- **2025-01** — Launched Aplo Scope to expand single-molecule super-resolution microscopy offering.
- **2024-07** — Featured in European Business Magazine as a rising disruptor in life sciences.
- **2023-02** — Appointed Paul Scagnetti as CEO to lead the next chapter of growth; founder Bo Jing transitioned from CEO.
- **2022-01** — Closed $75M Series B led by ARCH Venture Partners and Casdin Capital.

## Links

- Website: https://oni.bio
- LinkedIn: https://www.linkedin.com/company/onibio
- Twitter/X: https://twitter.com/oniHQ
- YouTube: https://www.youtube.com/@oni-bio
- Instagram: https://www.instagram.com/oni_bio/
- Facebook: https://www.facebook.com/ONIdotBIO/

---

Profile page: https://yespress.io/oni
Published by YesPress — https://yespress.io
Last updated: 2026-06-08